Key Financial Highlights:
- Q1 2026 revenues:
$16.9 million , exceeding the top end of our guidance - Q1 2026 gross margin: 62.2% GAAP; 65.2% non-GAAP, exceeding the top end of our guidance
- Cash, cash equivalents and short-term deposits as of
March 31, 2026 :$86.1 million
"The first quarter of 2026 exceeded our expectations, as we once again beat the top end of our guidance," said
Q1 2026 Financial Highlights:
- Q1 2026 revenues reached
$16.9 million , exceeding our guidance of$16.3-$16.7 million , compared to$19.4 million in Q4 2025 and$16.8 million in Q1 2025.- Q1 2026 Cross-Industry Business ("CIB") revenues accounted for approximately 65% of total revenues at
$11.0 million compared to$13.9 million in Q4 2025 and$11.7 million in Q1 2025. - Q1 2026 Automotive revenues accounted for approximately 35% of total revenues at
$5.9 million , compared to$5.5 million in Q4 2025 and$5.1 million in Q1 2025.
- Q1 2026 Cross-Industry Business ("CIB") revenues accounted for approximately 65% of total revenues at
- Q1 2026 GAAP gross margin was 62.2% (non-GAAP gross margin was 65.2%), above the guidance of 57%-59%. This is compared to a GAAP gross margin of 60.5% for Q4 2025 and 62.9% for Q1 2025 (non-GAAP gross margin of 63.9% in Q4 2025 and 66.7% in Q1 2025). On a segment basis, Q1 2026 gross margin from the CIB was 70.8% and gross margin from Automotive was 46.2%. This compares to Q4 2025 gross margins on a segment basis of 66.4% and 45.9%, respectively, and Q1 2025 gross margins on a segment basis of 69.1% and 48.4%, respectively. The increase in gross margin of the CIB compared to Q4 2025 was primarily due to product mix.
- Q1 2026 GAAP net loss amounted to
$(8.3) million , compared to a net loss of$(8.8) million in Q4 2025 and a net loss of$(8.3) million in Q1 2025. - Q1 2026 adjusted EBITDA was a loss of
$(5.5) million , which was lower than the previous guidance range of a$(7.9)-$(7.5) million adjusted EBITDA loss. This compares to an adjusted EBITDA loss of$(4.3) million in Q4 2025 and an adjusted EBITDA loss of$(4.3) million in Q1 2025. - Cash, cash equivalents and short-term deposits as of
March 31, 2026 , were$86.1 million and no debt. This compares to a cash balance of$92.6 million as ofDecember 31, 2025 and$112.5 million as ofMarch 31, 2025 .
Financial Outlook for Q2 2026
For Q2 2026, Valens expects revenues to range between
Disclaimer:
Conference Call Information
A live webcast of the conference call will be available via the investor relations section of
NYSE Rule 203.01 Annual Financial Report Announcement
Pursuant to Rule 203.01 of the New York Stock Exchange Manual,
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "will," "expect," "anticipate," "believe," "seek," "target" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding our anticipated future results, including financial results, our anticipated growth projections, our ability to concentrate our resources on our core businesses, our expectations regarding future revenues, gross margin, and adjusted EBITDA loss, and future economic and market conditions. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of
About Valens Semiconductor
SUMMARY OF FINANCIAL RESULTS | |||
( | |||
Three Months Ended | |||
2026 | 2025 | ||
Revenues | 16,859 | 16,828 | |
Gross Profit | 10,487 | 10,582 | |
Gross Margin | 62.2 % | 62.9 % | |
Net Loss | (8,290) | (8,308) | |
Working Capital1 | 91,279 | 119,820 | |
Cash, Cash Equivalents and Short-Term Deposits2 | 86,117 | 112,540 | |
(5,132) | (7,611) | ||
Non-GAAP Financial Data | |||
Non-GAAP Gross Margin3 | 65.2 % | 66.7 % | |
Adjusted EBITDA Loss4 | (5,466) | (4,346) | |
Non-GAAP Loss Per Share5 (in | |||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS | |||
( | |||
Three Months Ended | |||
2026 | 2025 | ||
REVENUES | 16,859 | 16,828 | |
COST OF REVENUES | (6,372) | (6,246) | |
GROSS PROFIT | 10,487 | 10,582 | |
OPERATING EXPENSES: | |||
Research and development expenses | (10,294) | (10,590) | |
Sales and marketing expenses | (5,396) | (5,607) | |
General and administrative expenses | (4,017) | (3,667) | |
Change in earnout liability | 282 | (174) | |
TOTAL OPERATING EXPENSES | (19,425) | (20,038) | |
OPERATING LOSS | (8,938) | (9,456) | |
Financial income, net | 673 | 1,238 | |
LOSS BEFORE INCOME TAXES | (8,265) | (8,218) | |
INCOME TAXES | (27) | (93) | |
LOSS AFTER INCOME TAXES | (8,292) | (8,311) | |
Equity in earnings of investee | 2 | 3 | |
NET LOSS | (8,290) | (8,308) | |
EARNINGS PER SHARE DATA: BASIC AND DILUTED NET LOSS PER | |||
WEIGHTED AVERAGE NUMBER OF SHARES IN COMPUTING NET LOSS PER ORDINARY | 105,047,377 | 105,255,959 | |
Change in unrealized losses on cash flow | (364) | (542) | |
TOTAL COMPREHENSIVE LOSS | (8,654) | (8,850) | |
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
( | ||||||
ASSETS | ||||||
CURRENT ASSETS Cash and cash equivalents | 28,970 | 27,863 | ||||
Short-term deposits | 57,147 | 64,733 | ||||
Restricted Short-term deposit | 1,144 | 1,132 | ||||
Trade accounts receivable | 10,475 | 9,971 | ||||
Inventories | 10,906 | 10,117 | ||||
Prepaid expenses and other current assets | 4,316 | 4,842 | ||||
TOTAL CURRENT ASSETS | 112,958 | 118,658 | ||||
LONG-TERM ASSETS: | ||||||
Property and equipment, net | 2,776 | 2,901 | ||||
Operating lease right-of-use assets | 6,645 | 6,901 | ||||
Intangible assets | 3,526 | 3,762 | ||||
Goodwill | 1,847 | 1,847 | ||||
Other assets | 668 | 632 | ||||
TOTAL LONG-TERM ASSETS | 15,462 | 16,043 | ||||
TOTAL ASSETS | 128,420 | 134,701 | ||||
LIABILITIES AND EQUITY CURRENT LIABILITIES | 21,679 | 22,934 | ||||
LONG-TERM LIABILITIES | ||||||
Non-current operating leases liabilities | 6,390 | 6,717 | ||||
Other long-term liabilities | 111 | 67 | ||||
TOTAL LONG-TERM LIABILITIES | 6,501 | 6,784 | ||||
TOTAL LIABILITIES | 28,180 | 29,718 | ||||
TOTAL SHAREHOLDERS' EQUITY | 100,240 | 104,983 | ||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 128,420 | 134,701 | ||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
( | |||||||
Three Months Ended | |||||||
2026 | 2025 | ||||||
CASH FLOW FROM OPERATING ACTIVITIES | |||||||
Net loss for the period | (8,290) | (8,308) | |||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Income and expense items not involving cash flows: | |||||||
Depreciation and amortization | 618 | 770 | |||||
Stock-based compensation | 3,136 | 4,166 | |||||
Exchange rate differences | 149 | 140 | |||||
Realized and unrealized Loss (gain) on non-designated derivative instruments | 5 | (204) | |||||
Interest on short-term deposits | (327) | 517 | |||||
Change in earnout liability | (282) | 174 | |||||
Reduction in the carrying amount of ROU assets | 310 | 418 | |||||
Equity in earnings of investee, net of dividend received | (2) | (3) | |||||
Changes in operating assets and liabilities: | |||||||
Trade accounts receivable | (509) | (1,800) | |||||
Prepaid expenses and other current assets | 235 | 825 | |||||
Inventories | (789) | (762) | |||||
Other assets | (24) | (115) | |||||
Current Liabilities | 973 | (3,196) | |||||
Change in operating lease liabilities | (379) | (230) | |||||
Other long-term liabilities | 44 | (3) | |||||
Net cash used in operating activities | (5,132) | (7,611) | |||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
Investment in short-term deposits | (5,664) | (30,005) | |||||
Maturities of short-term deposits | 13,565 | 53,278 | |||||
Purchase of property and equipment | (437) | (357) | |||||
Derivative instruments of non-designated hedges | (5) | (265) | |||||
Net cash provided by investing activities | 7,459 | 22,651 | |||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
Repurchase of Ordinary Shares | - | (9,585) | |||||
Earnout Payment | (1,962) | - | |||||
Exercise of stock options | 775 | 188 | |||||
Net cash provided by (used in) financing activities | (1,187) | (9,397) | |||||
Effect of exchange rate changes on cash and cash equivalents | (33) | (69) | |||||
INCREASE IN CASH AND CASH EQUIVALENTS | 1,107 | 5,574 | |||||
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD | 27,863 | 35,423 | |||||
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD | 28,970 | 40,997 | |||||
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES | |||||||
Trade accounts payable on account of property and equipment | 180 | 62 | |||||
Operating lease liabilities arising from obtaining operating right-of-use assets | 54 | 213 | |||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES | |||||||
( | |||||||
The following table provides a reconciliation of Net loss to Adjusted EBITDA, a non-GAAP measure. Adjusted EBITDA is defined as Net profit (loss) before financial income (expense), net, income taxes, equity in earnings of investee and depreciation and amortization, further adjusted to exclude share-based compensation and change in earnout liability, which may vary from period-to-period. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by other issuers, because not all issuers calculate Adjusted EBITDA in the same manner. Adjusted EBITDA should not be considered as an alternative to Net loss or any other performance measures derived in accordance with GAAP or as an alternative to cash flows from operating activities as a measure of our liquidity.
| |||||||
Although we provide guidance for Adjusted EBITDA, we are not able to provide guidance for projected Net profit (loss), the most directly comparable GAAP measures. Certain elements of Net profit (loss), including share-based compensation expenses and warrant valuations, are not predictable due to the high variability and difficulty of making accurate forecasts. As a result, it is impractical for us to provide guidance on Net profit (loss) or to reconcile our Adjusted EBITDA guidance without unreasonable efforts. Consequently, no disclosure of projected Net profit (loss) is included. For the same reasons, we are unable to address the probable significance of the unavailable information. | |||||||
Three Months Ended | |||||||
2026 | 2025 | ||||||
Net Loss | (8,290) | (8,308) | |||||
Adjusted to exclude the following: | |||||||
Change in earnout liability | (282) | 174 | |||||
Financial income, net | (673) | (1,238) | |||||
Income taxes | 27 | 93 | |||||
Equity in earnings of investee | (2) | (3) | |||||
Depreciation and amortization | 618 | 770 | |||||
Stock-based compensation expenses | 3,136 | 4,166 | |||||
Adjusted EBITDA Loss | (5,466) | (4,346) | |||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES | ||
( | ||
The following tables provide a calculation of the GAAP Loss per share and reconciliation to Non-GAAP Loss per share. | ||
Three Months Ended | ||
GAAP Loss per Share | 2026 | 2025 |
GAAP Net Loss used for computing Loss per Share | (8,290) | (8,308) |
Earnings Per Share Data: | ||
GAAP Loss per Share (in | ||
Weighted average number of shares and vested RSUs used in computing net loss per ordinary share | 105,047,377 | 105,255,959 |
Three Months Ended | ||
Non-GAAP Loss per Share7 | 2026 | 2025 |
GAAP Net Loss | (8,290) | (8,308) |
Adjusted to exclude the following: | ||
Stock based compensation | 3,136 | 4,166 |
Depreciation and amortization | 618 | 770 |
Change in earnout liability | (282) | 174 |
Total Non-GAAP Loss used for computing Loss per Share | (4,818) | (3,198) |
Earnings Per Share Data: | ||
Non-GAAP Loss per Share (in | ||
Weighted average number of shares and vested RSUs used in computing net loss per ordinary share | 105,047,377 | 105,255,959 |
1 Working Capital is calculated as Total Current Assets, less Total Current Liabilities, as of the last day of the period.
2 As of the last day of the period.
3 Non-GAAP Gross Margin is defined as: GAAP Gross Profit excluding share-based compensation and depreciation and amortization expenses, divided by revenue. For the three months ended
4 Adjusted EBITDA is defined as Net profit (loss) before financial income (expense), net, income taxes, equity in earnings of investee, and depreciation and amortization, further adjusted to exclude share-based compensation and change in fair value of Forfeiture Shares and in earnout liability, which may vary from period-to-period. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by other issuers, because not all issuers calculate Adjusted EBITDA in the same manner. Adjusted EBITDA should not be considered as an alternative to Net loss or any other performance measures derived in accordance with GAAP or as an alternative to cash flows from operating activities as a measure of our liquidity. Please refer to the appendix at the end of this press release for a reconciliation to the most directly comparable measure in accordance with GAAP.
5 See reconciliation of GAAP to non-GAAP financial measures.
6 See footnote 5
7 The company calculates its non-GAAP Loss per Share as GAAP Net Loss adjusted to exclude the following: Stock based compensation, depreciation and amortization, and the change in fair value of earnout liability divided by the weighted average number of shares used in calculation of net loss per share.
Infographic: https://mma.prnewswire.com/media/2979022/Valens_Semiconductor_Infographic.jpg
Logo: https://mma.prnewswire.com/media/2309625/4474760/Valens_Semiconductor_Logo.jpg
For more information, please contact:
Investor Contacts:
Investor Relations Manager
michal.benari@valens.com
MS-
msegal@ms-ir.com
Media Contact:
Head of Communications
yoni.dayan@valens.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/valens-semiconductor-reports-first-quarter-2026-results-302770764.html
SOURCE